⌘K

Login Start Free

Home/Filings/4/0001104659-20-005577

4//SEC Filing

Orlinger Klaus 4

Accession 0001104659-20-005577

CIK 0001760542other

View on SEC.gov Company Profile

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 4:44 PM ET

Size

17.0 KB

Accession

0001104659-20-005577

Insider Transaction Report

Form 4

Period: 2020-01-16

HOOKIPA Pharma Inc.HOOK

Sr. VP, Research

Transactions

Exercise/Conversion
Common Stock
2020-01-16$0.10/sh+571$57→ 1,711 total
Sale
Common Stock
2020-01-16$11.56/sh−1,711$19,781→ 0 total
Exercise/Conversion
Stock Option (Right to Buy)
2020-01-16−571→ 14,530 total
Exercise: $0.10Exp: 2026-12-31→ Common Stock (571 underlying)
Exercise/Conversion
Common Stock
2020-01-16$0.10/sh+1,140$114→ 1,140 total
Sale
Common Stock
2020-01-21$12.02/sh−6,789$81,592→ 0 total
Exercise/Conversion
Common Stock
2020-01-21$0.10/sh+6,789$679→ 6,789 total
Exercise/Conversion
Stock Option (Right to Buy)
2020-01-16−1,140→ 0 total
Exercise: $0.10Exp: 2026-12-31→ Common Stock (1,140 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2020-01-21−6,789→ 7,741 total
Exercise: $0.10Exp: 2026-12-31→ Common Stock (6,789 underlying)

Footnotes (2)

[F1]This option is fully vested and exercisable.
[F2]25% of this option vested and became exercisable on January 1, 2018, with the remainder vesting in 12 equal quarterly installments thereafter.

Documents

1 file

4
a4.xmlPrimary
4

Issuer

HOOKIPA Pharma Inc.

CIK 0001760542

Entity typeother

Related Parties

1

filerCIK 0001768432

Filing Metadata

Form type: 4
Filed: Jan 20, 7:00 PM ET
Accepted: Jan 21, 4:44 PM ET
Size: 17.0 KB

View on SEC.gov